Impact on Psychosocial Outcomes of a Nationally Available Weight Management Program Tailored for Individuals with Type 2 Diabetes: Results of a Randomized Controlled Trial
Aims Type 2 diabetes mellitus (T2DM) can substantially decrease quality of life (QOL). This study examined the effects on QOL-relevant psychosocial measures of a widely available commercial weight loss program enhanced for individuals with T2DM. Methods A year-long multi-site randomized clinical trial compared the Weight Watchers (WW) approach, supplemented with phone and email counseling with a certified diabetes educator (CDE), to brief standard diabetes nutrition counseling and education (Standard Care; SC). Participants were 400 women and 163 men (N=279 WW; 284 SC) with T2DM [mean (±SD) HbA1c8.32±1%; BMI=37.1±5.7kg/m2; age=55.1 ± 9.1years]. Psychosocial outcomes were assessed at baseline, month 6, and month 12 using a diabetes specific psychosocial measure (Diabetes Distress Scale [DDS]), Impact of Weight on Quality of Life-Lite scale (IWQOL), a generic QOL measure (SF-36), and a depression screen (PHQ-9). Results WW participants showed significantly greater improvements than did SC participants on all DDS subscales and total score and on IWQOL total score and physical function, sex life and work domains (allps<.05). There was no significant treatment effect on SF-36 scores or PHQ-9. Conclusions WW enhanced for individuals with T2DM was superior to SC in improving psychosocial outcomes most specific to T2DM and obesity. Available commercial WL programs, combined with scalable complementary program-specific diabetes counseling, may have benefits that extend to diabetes-related distress and weight-relevant QOL..
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:31 |
---|---|
Enthalten in: |
Journal of diabetes and its complications - 31(2017), 5, Seite 891 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Holland-Carter, Lauren [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cardiovascular disease |
---|
doi: |
10.1016/j.jdiacomp.2017.01.022 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC1993003819 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | OLC1993003819 | ||
003 | DE-627 | ||
005 | 20230715044240.0 | ||
007 | tu | ||
008 | 170512s2017 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jdiacomp.2017.01.022 |2 doi | |
028 | 5 | 2 | |a PQ20170501 |
035 | |a (DE-627)OLC1993003819 | ||
035 | |a (DE-599)GBVOLC1993003819 | ||
035 | |a (PRQ)c1047-e1ba37d797f6f7443e1ae5be789de60b2bdf0faf06b48b2524245541fd0aca150 | ||
035 | |a (KEY)0146708520170000031000500891impactonpsychosocialoutcomesofanationallyavailable | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q DNB |
100 | 1 | |a Holland-Carter, Lauren |e verfasserin |4 aut | |
245 | 1 | 0 | |a Impact on Psychosocial Outcomes of a Nationally Available Weight Management Program Tailored for Individuals with Type 2 Diabetes: Results of a Randomized Controlled Trial |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
520 | |a Aims Type 2 diabetes mellitus (T2DM) can substantially decrease quality of life (QOL). This study examined the effects on QOL-relevant psychosocial measures of a widely available commercial weight loss program enhanced for individuals with T2DM. Methods A year-long multi-site randomized clinical trial compared the Weight Watchers (WW) approach, supplemented with phone and email counseling with a certified diabetes educator (CDE), to brief standard diabetes nutrition counseling and education (Standard Care; SC). Participants were 400 women and 163 men (N=279 WW; 284 SC) with T2DM [mean (±SD) HbA1c8.32±1%; BMI=37.1±5.7kg/m2; age=55.1 ± 9.1years]. Psychosocial outcomes were assessed at baseline, month 6, and month 12 using a diabetes specific psychosocial measure (Diabetes Distress Scale [DDS]), Impact of Weight on Quality of Life-Lite scale (IWQOL), a generic QOL measure (SF-36), and a depression screen (PHQ-9). Results WW participants showed significantly greater improvements than did SC participants on all DDS subscales and total score and on IWQOL total score and physical function, sex life and work domains (allps<.05). There was no significant treatment effect on SF-36 scores or PHQ-9. Conclusions WW enhanced for individuals with T2DM was superior to SC in improving psychosocial outcomes most specific to T2DM and obesity. Available commercial WL programs, combined with scalable complementary program-specific diabetes counseling, may have benefits that extend to diabetes-related distress and weight-relevant QOL. | ||
650 | 4 | |a Obesity | |
650 | 4 | |a Weight control | |
650 | 4 | |a Studies | |
650 | 4 | |a Counseling | |
650 | 4 | |a Clinical trials | |
650 | 4 | |a Diabetes | |
650 | 4 | |a Nutrition research | |
650 | 4 | |a Cardiovascular disease | |
650 | 4 | |a Dietitians | |
650 | 4 | |a Diet | |
650 | 4 | |a Gastrointestinal surgery | |
650 | 4 | |a Quality of life | |
650 | 4 | |a Mental depression | |
700 | 1 | |a Tuerk, Peter W |4 oth | |
700 | 1 | |a Wadden, Thomas A |4 oth | |
700 | 1 | |a Fujioka, Ken N |4 oth | |
700 | 1 | |a Becker, Lynne E |4 oth | |
700 | 1 | |a Miller-Kovach, Karen |4 oth | |
700 | 1 | |a Hollander, Priscilla L |4 oth | |
700 | 1 | |a Garvey, W. Timothy |4 oth | |
700 | 1 | |a Weiss, Daniel |4 oth | |
700 | 1 | |a Rubino, Domenica M |4 oth | |
700 | 1 | |a Kushner, Robert F |4 oth | |
700 | 1 | |a Malcolm, Robert J |4 oth | |
700 | 1 | |a Raum, William J |4 oth | |
700 | 1 | |a Hermayer, Kathie L |4 oth | |
700 | 1 | |a Veliko, Jan L |4 oth | |
700 | 1 | |a Rost, Stephanie L |4 oth | |
700 | 1 | |a Sora, Nicoleta D |4 oth | |
700 | 1 | |a Salyer, Jonny L |4 oth | |
700 | 1 | |a O'Neil, Patrick M |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Journal of diabetes and its complications |d New York, NY : Elsevier, 1992 |g 31(2017), 5, Seite 891 |w (DE-627)170786293 |w (DE-600)1105840-7 |w (DE-576)038688239 |x 1056-8727 |7 nnns |
773 | 1 | 8 | |g volume:31 |g year:2017 |g number:5 |g pages:891 |
856 | 4 | 1 | |u http://dx.doi.org/10.1016/j.jdiacomp.2017.01.022 |3 Volltext |
856 | 4 | 2 | |u http://search.proquest.com/docview/1890235787 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a GBV_ILN_4219 | ||
951 | |a AR | ||
952 | |d 31 |j 2017 |e 5 |h 891 |